Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms
线粒体偕胺肟还原成分 1 和羟基类固醇 17-β 脱氢酶 13 的变体可降低儿童非酒精性脂肪性肝病的严重程度，并通过不同的机制抑制纤维化途径
期刊:Hepatology Communications
影响因子:5.6
doi:10.1002/hep4.1955
Christian A Hudert, Leon A Adams, Anna Alisi, Quentin M Anstee, Annalisa Crudele, Laura G Draijer, Samuel Furse, Jan G Hengstler, Benjamin Jenkins, Kylie Karnebeek, Deirdre A Kelly, Bart G Koot, Albert Koulman, David Meierhofer, Phillip E Melton, Trevor A Mori, Stuart G Snowden, Indra van Mourik, An
